%0 Journal Article
%T Development of Screening Tools for the Interpretation of Chemical Biomonitoring Data
%A Richard A. Becker
%A Sean M. Hays
%A Steven Robison
%A Lesa L. Aylward
%J Journal of Toxicology
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/941082
%X Evaluation of a larger number of chemicals in commerce from the perspective of potential human health risk has become a focus of attention in North America and Europe. Screening-level chemical risk assessment evaluations consider both exposure and hazard. Exposures are increasingly being evaluated through biomonitoring studies in humans. Interpreting human biomonitoring results requires comparison to toxicity guidance values. However, conventional chemical-specific risk assessments result in identification of toxicity-based exposure guidance values such as tolerable daily intakes (TDIs) as applied doses that cannot directly be used to evaluate exposure information provided by biomonitoring data in a health risk context. This paper describes a variety of approaches for development of screening-level exposure guidance values with translation from an external dose to a biomarker concentration framework for interpreting biomonitoring data in a risk context. Applications of tools and concepts including biomonitoring equivalents (BEs), the threshold of toxicologic concern (TTC), and generic toxicokinetic and physiologically based toxicokinetic models are described. These approaches employ varying levels of existing chemical-specific data, chemical class-specific assessments, and generic modeling tools in response to varying levels of available data in order to allow assessment and prioritization of chemical exposures for refined assessment in a risk management context. 1. Introduction Recognition of the large numbers of chemicals in commerce and increased focus on evaluation of these chemicals from the perspective of potential human health risk has become a focus of attention in North America and Europe. These efforts are devoted not only to evaluation of ¡°new¡± chemicals but also to an examination of existing chemical substances. These efforts include those under the Health Canada Chemicals Management Plan, the European Registration, Evaluation, Authorisation and Restriction of Chemicals (REACh), the High Production Volume (HPV) Challenge Program, and the US Environmental Protection Agency¡¯s (US EPA) Chemical Assessment and Management Program (ChAMP) initiatives. Chemical evaluation is also being discussed as part of potential improvements to the US Toxic Substances Control Act. Because of the large number of chemicals involved and the need for efficient processes that assure focus on substances which could pose the greatest health concerns, tiered approaches that begin with conservative risk-based screening-level assumptions and proceed to more refined
%U http://www.hindawi.com/journals/jt/2012/941082/